Country / RegionValuation protocolYear of data collectionPublication
CanadaEQ-VT v1.02012Xie F, Pullenayegum E, Gaebel K, Bansback N, Bryan S, Ohinmaa A, Poissant L, Johnson JA. A Time Trade-off-derived Value Set of the EQ-5D-5L for Canada. Med Care. 2016;54(1):98-105.
England *EQ-VT v1.02012Devlin N, Shah K, Feng Y, Mulhern B, van Hout B. Valuing health-related quality of Life: An EQ-5D-5L Value Set for England. Health Economics. 2017;1-16
JapanEQ-VT v1.12013Shiroiwa T, Ikeda S, Noto S, Igarashi A, Fukuda T, Saito S, Shimozuma K. Comparison of Value Set Based on DCE and/or TTO Data: Scoring for EQ-5D-5L Health States in Japan. Value Health. 2016 Jul-Aug;19(5):648-54.
KoreaEQ-VT v1.12013Kim SH, Ahn J, Ock M, Shin S, Park J, Luo N, Jo MW. The EQ-5D-5L valuation study in Korea. Qual Life Res. 2016 Jul;25(7):1845-52.
NetherlandsEQ-VT v1.02012Versteegh MM, Vermeulen KM, Evers SM, de Wit GA, Prenger R, Stolk EA. Dutch Tariff for the Five-Level Version of EQ-5D. Value Health. 2016;19(4):343-52.
UruguayEQ-VT v1.12013Augustovski F, Rey-Ares L, Irazola V, Garay OU, Gianneo O, Fern‡ndez G, Morales M, Gibbons L, Ramos-Go–i JM. An EQ-5D-5L value set based on Uruguayan population preferences. Qual Life Res. 2016;25(2):323-33. Erratum in: Qual Life Res. 2016 Feb;25(2):335.
ChinaEQ-VT v1.02012Luo N, Liu G, Li M, Guan H, Jin X, Rand-Hendriksen K. Estimating an EQ-5D-5L Value Set for China. Value Health. 2017 Apr;20(4):662-669. doi: 10.1016/j.jval.2016.11.016. Epub 2017 Feb 9.
IndonesiaEQ-VT v2.02015Purba FD, Hunfeld JAM, Iskandarsyah A, Fitriana TS, Sadarjoen SS, Ramos-Goñi JM, Passchier J, Busschbach JJ. The Indonesian EQ-5D-5L Value Set. PharmacoEconomics. 2017 July;
DOI 10.1007/s40273-017-0538-9. pp 1–13.
SpainEQ-VT v1.02012Ramos-Goñi JM, Craig B, Oppe M, Ramallo-Fariña Y, Pinto-Prades JL, Luo N, Rivero-Arias O. Handling data quality issues to estimate the Spanish EQ-5D-5L Value Set using a hybrid interval regression approach.  Value in Health 2017. In Press
Hong KongEQ-VT v1.12014Wong ELY, Ramos-Goñi JM, Cheung AWL, Wong AYK, Rivero-Arias O. Assessing the Use of a Feedback Module to Model EQ-5D-5L Health States Values in Hong Kong. Patient. 2017 Oct 10. doi: 10.1007/s40271-017-0278-0. [Epub ahead of print]
GermanyEQ-VT v2.02015Ludwig K, Graf von der Schulenburg JM, Greiner W. German Value Set for the EQ-5D-5L.
Pharmacoeconomics. 2018 Feb 19. doi: 10.1007/s40273-018-0615-8. [Epub ahead of print]
ThailandEQ-VT v1.12013-2014Pattanaphesaj J, Thavorncharoensap M, Ramos-
Goñi JM, Tongsiri S, Ingsrisawang L, Teerawattananon Y. The EQ-5D-5L Valuation study in Thailand. Expert Review of Pharmacoeconomics & Outcomes Research, DOI: 10.1080/14737167.2018.1494574
IrelandEQ-VT v2.02015-2016Hobbins A, Barry L, Kelleher D, Shah K, Devlin N, Ramos Goni JM, O’Neill C. Utility Values for Health States in Ireland: A Value Set for the EQ‑5D‑5L. PharmacoEconomics (2018)
MalaysiaEQ-VT v2.02016Shafie AA; Vasan Thakumar A; Lim CJ;Luo N; Rand-Hendriksen K; Yusof FA. EQ-5D-5L Valuation for the Malaysian Population. PharmacoEconomics (2018)
TaiwanEQ-VT v2.02017Lin HW, Li CI, Lin FJ, Chang JY, Gau CS, Luo N, Pickard AS, Ramos Goñi JM, Tang CH, Hsu CN . Valuation of the EQ-5D-5L in Taiwan
. PLoS One. 2018; 13(12)
PolandEQ-VT v2.02016Golicki D, Jakubczyk M, Graczyk K, Niewada M. Valuation of EQ‑5D‑5L Health States in Poland: the First EQ‑VT‑Based
Study in Central and Eastern Europe. PharmacoEconomics (2019) 37:1165–1176
PortugalEQ-VT v2.02015-2016Ferreira P, Antunes P, Ferreira L, Pereira L, Ramos-Goñi JM. A hybrid modelling approach for eliciting health state preferences: the Portuguese EQ-5D-5L value set.. Qual Life Res (2019)
USAEQ-VT v2.02017Pickard S, Law E, Jiang R, Pullenayegum E, Shaw J, Xie F, Oppe F, Boye K, Chapman R, Gong C, Balch A, Busschbach J. United States Valuation of EQ-5D-5L Health States Using an International Protocol. VALUE HEALTH. 2019; 22(8):931–941
FranceEQ-VT v2.02018Andrade L, Ludwig K, Ramos Goni J, Oppe M, de Pouvourville G. A French Value Set for the EQ‑5D‑5L. PharmacoEconomics (2020)
EthiopiaEQ-PVT2019Welie A, Gebretkle G, Stolk E, Mukuria C, Krahn M, Enquoselassi F, Fenta T. Valuing Health State: An EQ-5D-5L Value Set for Ethiopians. Value in Health (2020) 22:7-4
VietnamEQ-VT v2.02017Mai V, Sun S, Van Minh H, Luo N, Kim Giang K, Lindholm L, Sahlen K. An EQ-5D-5L Value Set for Vietnam. Qual Life Res (2019)
HungaryEQ-VT v2.12018-2019Rencz F, Brodszky V, Gulacsi L, Golicki D, Ruzsa G, Pickard S, Law E, Pentek M. Parallel Valuation of the EQ-5D-3L and EQ-5D-5L by Time Trade-Off in Hungary. Value in Health. 2020; 23(9):1235–1245
DenmarkEQ-VT v2.12018-2019Jensen C, Sørensen S, Gudex C, Jensen M, Pedersen K, Ehlers L. The Danish EQ-5D-5L Value Set: A Hybrid Model Using cTTO and DCE Data. Appl Health Econ Health Policy (2021)
EgyptEQ-VT v2.12019-2020Al Shabasy S, Abbassi M, Finch A, Roudijk B, Baines D, Farid S. The EQ-5D-5L Valuation Study in Egypt. PharmacoEconomics (2021)
BelgiumEQ-VT v2.12018-2020Bouckaert N, Cleemput I, Devriese S, Gerkens S . An EQ-5D-5L value set for Belgium. PharmacoEconomics-Open, 6(6), 823-836
IndiaEQ-VT v2.12019-2020Jyani G, Prinja G, Kar S, Trivedi M, Patro B, Purba F, Pala S, Raman S, Sharma A, Jain S, Kaur M. Valuing health-related quality of life among the Indian population: a protocol for the Development of an EQ-5D Value set for India using an Extended design (DEVINE) Study. VALUE HEALTH. 2022; 25(7):1218–1226
MexicoEQ-VT v2.12019Gutierrez-D C, Galindo-S R, Cruz-S C, Shah L, Papadimitropoulos M, Feng Y, Zamora B, Devlin N. EQ-5D-5L Health-State Values for the Mexican Population. Appl Health Econ Health Policy. 2021 Jun 26
PeruEQ-VT v2.12018-2019Augustovski F, Belizán M, Gibbons L, Reyes N, Stolk E, Craig B, Tejada R
. Peruvian Valuation of the EQ-5D-5L: A Direct Comparison of Time Trade-Off and Discrete Choice Experiments. Value Health. 2020 Jul;23(7):880-888.
UgandaEQ-VT Lite2021Yang F,Katumba K,Roudijk B,Yang Z,Revill P,Grifn S,Ochanda P,Lamorde M,Greco G,Seeley J,Sculpher M. Developing the EQ-5D-5L Value Set for Uganda Using the ‘Lite’ Protocol. PharmacoEconomics, 2021
ItalyEQ-VT v2.12020-2021Finch A, Meregaglia M, Ciani O, Roudijk B, Jommi C. An EQ-5D-5L value set for Italy using videoconferencing interviews and feasibility of a new mode of administration. Social Science & Medicine
Volume 292, January 2022
RomaniaEQ-VT v2.12018-2019Olariu, E., Mohammed, W., Oluboyede, Y., Caplescu, R., Niculescu-Aron, I. G., Paveliu, M. S., & Vale, L.. EQ-5D-5L: a value set for Romania.. The European Journal of Health Economics, 1-14.
SwedenEQ-VT v2.12020-2021Sun S, Chuang L, Sahlén G, Lindholm L, Norström F. Estimating a social value set for EQ-5D-5L in Sweden.. Health and Quality of Life Outcomes, 20(1), 167.
PhilippinesEQ-VT v2.02017Miguel R, Rivera A, Cheng K, Rand K, Purba F, Luo N, Lam H. Estimating the EQ-5D-5L value set for the Philippines.. Quality of Life Research, 31(9), 2763-2774.
AustraliaTTO, DCE duration2019Norman R, Mulhern B, Lancsar E, Lorgelly P, Ratcliffe J, Street D, Viney R. The Use of a Discrete Choice Experiment Including Both Duration and Dead for the Development of an EQ-5D-5L Value Set for Australia.. PharmacoEconomics, 1-12.
Back To Top